PortfoliosLab logo

Anavex Life Sciences Corp. (AVXL)

Equity · Currency in USD · Last updated Dec 3, 2022

Company Info

ISINUS0327973006
CUSIP032797300
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$12.05
Year Range$7.31 - $19.96
EMA (50)$11.28
EMA (200)$11.88
Average Volume$2.01M
Market Capitalization$939.44M

AVXLShare Price Chart


Loading data...

AVXLPerformance

The chart shows the growth of $10,000 invested in Anavex Life Sciences Corp. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $13,693 for a total return of roughly 36.93%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%JulyAugustSeptemberOctoberNovemberDecember
45.89%
-1.21%
AVXL (Anavex Life Sciences Corp.)
Benchmark (^GSPC)

AVXLCompare to other instruments

Search for stocks, ETFs, and funds to compare with AVXL

AVXLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.82%5.59%
6M43.97%-2.52%
YTD-30.51%-14.57%
1Y-32.72%-9.78%
5Y26.39%9.04%
10Y11.78%11.20%

AVXLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-24.57%-16.21%12.32%-30.22%6.05%9.88%2.50%-6.53%7.61%17.93%-27.53%36.62%
202116.30%107.32%14.82%-19.20%3.06%83.61%-21.48%8.58%-7.90%4.40%3.52%-10.62%
202010.42%33.22%-17.32%9.84%18.79%19.71%-14.23%0.47%7.31%29.67%-9.66%1.31%
201918.59%15.68%42.52%-2.62%-2.69%16.61%-24.04%3.13%19.70%-13.92%-11.76%7.92%
2018-12.11%-16.61%16.95%-17.39%20.61%-4.73%3.05%-1.11%2.25%-11.72%-4.98%-31.88%
201713.64%27.56%0.00%-1.92%2.84%-8.12%-23.68%9.36%-6.76%1.93%-9.95%-15.26%
2016-35.55%24.51%9.62%11.43%-18.68%37.61%-37.15%-20.31%18.63%-23.14%42.29%-0.25%
2015-5.95%9.20%11.05%37.44%37.93%12.50%102.24%48.34%4.44%87.59%-33.93%-20.31%
201436.00%4.41%26.76%-15.56%-10.53%2.94%-25.14%-4.58%-26.40%0.54%8.00%-7.41%
2013-8.86%-12.50%11.90%-7.80%-1.54%-6.25%-16.67%22.20%6.38%-21.54%-12.75%-43.82%
201238.52%3.55%-28.57%-35.18%54.28%-20.00%15.00%-5.22%-29.36%23.38%9.47%-24.04%
201116.44%-10.82%-5.01%-12.50%4.44%-30.09%0.00%-22.61%9.55%-0.51%-38.14%1.67%
2010-4.09%20.85%23.14%-17.20%25.00%6.46%-11.85%11.48%18.82%-20.54%33.33%-14.72%

AVXLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anavex Life Sciences Corp. Sharpe ratio is -0.37. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovemberDecember
-0.37
-0.46
AVXL (Anavex Life Sciences Corp.)
Benchmark (^GSPC)

AVXLDividend History


Anavex Life Sciences Corp. doesn't pay dividends

AVXLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-58.25%
-15.11%
AVXL (Anavex Life Sciences Corp.)
Benchmark (^GSPC)

AVXLWorst Drawdowns

The table below shows the maximum drawdowns of the Anavex Life Sciences Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anavex Life Sciences Corp. is 96.43%, recorded on Nov 19, 2014. It took 1651 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.43%Jan 21, 2011964Nov 19, 20141651Jun 14, 20212615
-74.67%Jun 29, 2021220May 11, 2022
-27.91%Mar 19, 201028Apr 28, 201019May 25, 201047
-24.76%Sep 28, 201017Oct 20, 201014Nov 9, 201031
-18.22%Dec 1, 20107Dec 9, 201025Jan 14, 201132
-17.39%Jun 15, 20211Jun 15, 20211Jun 16, 20212
-15.41%Jun 29, 201019Jul 26, 201028Sep 2, 201047
-13.91%Jan 20, 20104Jan 25, 201015Feb 16, 201019
-12.29%Mar 5, 20102Mar 8, 20101Mar 9, 20103
-6.82%Jan 6, 20103Jan 8, 20106Jan 19, 20109

AVXLVolatility Chart

Current Anavex Life Sciences Corp. volatility is 237.13%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
237.13%
20.47%
AVXL (Anavex Life Sciences Corp.)
Benchmark (^GSPC)